Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Yale University Pfizer |
---|---|
Information provided by: | Yale University |
ClinicalTrials.gov Identifier: | NCT00585455 |
To determine the effects of chronic sertraline treatment on brachial artery flow-mediated dilation in patients with chronic heart failure and depression
Condition | Intervention |
---|---|
Heart Failure Depression |
Drug: sertraline |
Study Type: | Observational |
Study Design: | Cohort, Prospective |
Official Title: | Effects of Chronic Sertraline Hydrochloride Administration on Vascular Endothelial and Autonomic Function in Patients With Chronic Heart Failure |
Plasma and serum
Estimated Enrollment: | 20 |
Study Start Date: | January 2006 |
Estimated Study Completion Date: | December 2008 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
A
Chronic heart failure patients with concomitant depression
|
Drug: sertraline
open label 25-50 mg daily as tolerated
|
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
chronic heart failure patients with concomitant depression
Inclusion Criteria:
Exclusion Criteria:
Contact: Stuart Katz, MD | 203-785-7191 | stuart.katz@yale.edu |
Contact: Patti Cavaliere | 203-785-7191 | patti.cavaliere@yale.edu |
United States, Connecticut | |
Yale University School of Medicine | Recruiting |
New Haven, Connecticut, United States, 06510 | |
Contact: Stuart Katz 203-785-7191 stuart.katz@yale.edu | |
Principal Investigator: Stuart Katz, MD |
Principal Investigator: | Stuart Katz, MD | Yale School of Medicine |
Responsible Party: | Yale University School of Medicine ( Stuart Katz ) |
Study ID Numbers: | 0410027131 |
Study First Received: | December 22, 2007 |
Last Updated: | June 12, 2008 |
ClinicalTrials.gov Identifier: | NCT00585455 |
Health Authority: | United States: Institutional Review Board |
vascular endothelium nitric oxide depression heart failure vascular biology |
Nitric Oxide Heart Failure Heart Diseases Depression Mental Disorders |
Mood Disorders Sertraline Depressive Disorder Serotonin Behavioral Symptoms |
Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Serotonin Agents Molecular Mechanisms of Pharmacological Action Therapeutic Uses Physiological Effects of Drugs |
Psychotropic Drugs Cardiovascular Diseases Serotonin Uptake Inhibitors Central Nervous System Agents Pharmacologic Actions Antidepressive Agents |